Keros Therapeutics (KROS) Cash from Investing Activities Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -122.45% |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | 53.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.63% |
| Sep 30, 2025 | 65.80% |
| Jun 30, 2025 | -132.26% |
| Mar 31, 2025 | 40.27% |
| Dec 31, 2024 | 46.58% |
| Sep 30, 2024 | 29.82% |
| Jun 30, 2024 | 0.32% |
| Mar 31, 2024 | 10.92% |
| Dec 31, 2023 | -54.13% |
| Sep 30, 2023 | -212.50% |
| Jun 30, 2023 | 45.15% |
| Mar 31, 2023 | -622.45% |
| Dec 31, 2022 | -120.75% |
| Sep 30, 2022 | -21.38% |
| Jun 30, 2022 | -11.18% |
| Mar 31, 2022 | 30.00% |
| Dec 31, 2021 | -165.00% |
| Sep 30, 2021 | -383.33% |
| Jun 30, 2021 | -1,721.43% |
| Mar 31, 2021 | -19.32% |
| Dec 31, 2020 | -233.33% |
| Sep 30, 2020 | 63.41% |
| Jun 30, 2020 | 83.63% |